KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Cash & Equivalents (2020 - 2026)

Organon has reported Cash & Equivalents over the past 7 years, most recently at $1.1 billion for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 104.02% year-over-year to $1.1 billion; the TTM value through Mar 2026 reached $1.1 billion, up 104.02%, while the annual FY2025 figure was $574.0 million, 14.96% down from the prior year.
  • Cash & Equivalents for Q1 2026 was $1.1 billion at Organon, up from $574.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.1 billion in Q1 2026 and troughed at $326.0 million in Q2 2023.
  • A 5-year average of $621.2 million and a median of $599.0 million in 2025 define the central range for Cash & Equivalents.
  • On a YoY basis, Cash & Equivalents climbed as much as 392.2% in 2022 and fell as far as 50.5% in 2022.
  • Year by year, Cash & Equivalents stood at $706.0 million in 2022, then decreased by 1.84% to $693.0 million in 2023, then fell by 2.6% to $675.0 million in 2024, then dropped by 14.96% to $574.0 million in 2025, then soared by 94.43% to $1.1 billion in 2026.
  • Business Quant data shows Cash & Equivalents for OGN at $1.1 billion in Q1 2026, $574.0 million in Q4 2025, and $672.0 million in Q3 2025.